Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
955
Introduction to R01:11

Introduction to R

4.4K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
4.4K
Interpreting R Charts01:22

Interpreting R Charts

504
R chart, or range chart, is a fundamental tool in statistical process control used to monitor the variability within a process. It complements the X-bar (x̄) chart by focusing on the range of the data, rather than individual values, providing a clear picture of the process dispersion over time.
An R chart plots the range of subsets of measurements collected from a process. Each point on the chart represents the range—defined as the difference between the maximum and minimum...
504

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessing surrogate heterogeneity in real world data using meta-learners.

Journal of causal inference·2026
Same author

Model-Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival.

Statistics in medicine·2025
Same author

RISE: Two-Stage Rank-Based Identification of High-Dimensional Surrogate Markers Applied to Vaccinology.

Statistics in medicine·2025
Same author

Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials.

Biometrics·2025
Same author

Robust evaluation of longitudinal surrogate markers with censored data.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2025
Same author

A General Framework to Assess Complex Heterogeneity in the Strength of a Surrogate Marker.

Statistics in medicine·2025
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
查看所有相关文章

相关实验视频

Updated: Apr 30, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

代孕标记评价:使用R的教程

Layla Parast1

  • 1Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, Texas, USA.

Statistics in medicine
|May 19, 2025
PubMed
概括
此摘要是机器生成的。

本研究审查了在临床试验中验证代孕标记物的统计方法. 它侧重于"治疗效果比例解释"框架,提供实用的R代码进行实施,并讨论未来的研究方向.

关键词:
生物标志物生物标志物审查 审查 审查实施实施实施实施实施.没有参数的非参数.代孕母亲是什么意思治疗效果治疗效果的治疗效果

更多相关视频

Author Spotlight: High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution
10:47

Author Spotlight: High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution

Published on: May 5, 2023

2.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

193

相关实验视频

Last Updated: Apr 30, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Author Spotlight: High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution
10:47

Author Spotlight: High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution

Published on: May 5, 2023

2.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

193

科学领域:

  • 生物统计学 生物统计学
  • 临床试验设计 临床试验设计
  • 药学研究 药学研究

背景情况:

  • 替代标记在临床研究中被广泛使用,作为主要结果的替代品.
  • 替代标记的验证对于可靠评估治疗有效性的替代标记至关重要.
  • 现有的统计和临床研究已经在35年内广泛探索了代孕标志物评估.

研究的目的:

  • 描述用于评估代用标记物的可用统计框架.
  • 专注于治疗效果解释比例 (PTE) 框架的实际实施.
  • 为实现这些程序提供R代码.

主要方法:

  • 对替代体标志物评估的统计框架的审查.
  • 专注于PTE框架,无论是未经审查的还是被审查的结果.
  • 包括参数和非参数估计方法.
  • 考虑多个替代品,异质性和预测视角.

主要成果:

  • 该教程详细介绍了替代标记器验证的各种统计方法.
  • 提供了使用R代码的实际实施指南.
  • 讨论包括高级主题,如代孕悖论和异质性.

结论:

  • PTE框架为代孕标志物评估提供了一种有价值的方法.
  • 需要进一步的研究,特别是使用代用标记物来测试未来研究中的治疗方法.
  • 该研究丰富了该领域的新见解和替代标记分析的实用工具.